Cyanotech Corporation

73-4460 Queen Kaahumanu
Kailua-Kona
Hawaii
96740
United States

Tel: 808-326-1353

About Cyanotech Corporation

Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®—all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's spirulina, FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use as a food ingredient, augments energy and immune response. BioAstin's benefits derive from its superior antioxidant activity and from its ability to fight free radical damage and combat ongoing oxidative stress, enhancing skin, muscle and joint health.

49 articles with Cyanotech Corporation

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021

6/22/2021

Cyanotech Corporation announced financial results for the fourth quarter and fiscal year 2021, ended March 31, 2021.
Cyanotech® Corporation Launches BioAstin®

10/1/2020

Cyanotech® Corporation, (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announces its launch of BioAstin® Hawaiian Astaxanthin® in a new delivery form, water dispersible powder, available in both 1% and 2% concentrations.
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2020

6/23/2020

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the fourth quarter and fiscal year 2020, ended March 31, 2020. Fiscal Year 2020 Cyanotech reported net sales of $31,899,000 for fiscal 2020 compared to $30,202,000 in fiscal 2019. Gross profit was $12,700,000, with gross profit margin of 39.8%,
Cyanotech® Donates Protein Powder and Medical Supplies to Local Hospitals

4/11/2020

Cyanotech®,, a world leader in microalgae-based, high-value nutrition and health products, has donated over 700 bottles of their Hawaiian Spirulina® Protein Shake and personal protective equipment to two Hawaii Island hospitals.
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020

2/11/2020

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the third quarter and first nine months of fiscal year 2020, ended December 31, 2019.
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2020

11/12/2019

Net sales increase 10.6% to $7,690,000, operating income was $409,000 for second quarter
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2020

8/13/2019

Net sales increase 13% to $8,071,000, operating income was $49,000
Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2019

7/1/2019

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the fourth quarter and fiscal year 2019, ended March 31, 2019.
Cyanotech® Corporation Earns Blue Zones® Certification

4/4/2019

Cyanotech Corporation,, a world leader in microalgae-based, high-value nutrition and health products, is proud to announce that it has joined the Blue Zones Project ‘Ohana.
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2019

2/13/2019

Net Sales Increase 9.8% to Record $10,044,000
Cyanotech Names Brian Orlopp as VP Finance & Chief Financial Officer

1/9/2019

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced that Brian B. Orlopp has been appointed Vice President Finance and Administration, Chief Financial Officer and Secretary effective January 3, 2019.
Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2019

8/13/2018

For the first quarter of fiscal 2019 compared to the first quarter of fiscal 2018, net sales were $7,145,000 compared to $8,809,000.
Cyanotech To Hold Investor Broadcast On Friday, August 11, 2017

8/7/2017
Cyanotech Reports Financial Results For The Third Quarter And First Nine Months Of Fiscal Year 2017

2/8/2017
Cyanotech Names Nancy Katz As A Director

10/26/2016
Cyanotech Reports Financial Results For The First Quarter Of Fiscal Year 2017

8/15/2016
Cyanotech Names David Mulder As A Director

5/23/2016
Founder Gerry Cysewski, Ph.D., Named Interim President & CEO Of Cyanotech

4/4/2016
Cyanotech Reports Financial Results For The First Quarter Of Fiscal Year 2016

8/7/2015
Cyanotech Adds Astaxanthin Productivity Enhancement

6/12/2015